Vericiguat approved in the US for treatment of chronic heart failure

It has been approved for use in adults with symptomatic chronic heart failure and ejection fraction <45%, to reduce the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics.

Biospace Inc.